Compounds > s 16020-2
Page last updated: 2024-09-05

s 16020-2 and Leukemia P388

s 16020-2 has been researched along with Leukemia P388 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atassi, G; Genissel, P; Goldstein, S; Guilbaud, N; Guillonneau, C; Kraus-Berthier, L; Léonce, S; Parker, T; Pierré, A1
Atassi, G; Bisagni, E; Burbridge, M; Guilbaud, N; Jan, M; Kraus-Berthier, L; Pierré, A; Rouillon, MH; Saint-Dizier, D; Visalli, M1
Atassi, G; Léonce, S; Pérez, V; Pierré, A1
Atassi, G; Bisagni, E; Charton, Y; Guilbaud, N; Guillonneau, C; Kraus-Berthier, L; Léonce, S; Michel, A1

Other Studies

4 other study(ies) available for s 16020-2 and Leukemia P388

ArticleYear
Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug.
    Cancer chemotherapy and pharmacology, 2002, Volume: 50, Issue:2

    Topics: Adenocarcinoma; Animals; Animals, Congenic; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Division; Drug Screening Assays, Antitumor; Ellipticines; Enzyme Inhibitors; Female; Humans; Leukemia P388; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Nude; Mice, SCID; Neoplasm Proteins; Organ Specificity; Ovarian Neoplasms; Prodrugs; Prostatic Neoplasms; Topoisomerase II Inhibitors; Vinblastine; Vinorelbine; Xenograft Model Antitumor Assays

2002
In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:6

    Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Blood Cell Count; Bone Marrow; Breast Neoplasms; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Ellipticines; Female; Humans; Injections, Intraperitoneal; Injections, Intravenous; Leukemia P388; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Tumor Cells, Cultured

1996
Circumvention of P-glycoprotein-mediated multidrug resistance by S16020-2: kinetics of uptake and efflux in sensitive and resistant cell lines.
    Cancer chemotherapy and pharmacology, 1998, Volume: 42, Issue:6

    Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Carbon Radioisotopes; Cell Division; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Ellipticines; Leukemia P388; Mice; Tritium; Tumor Cells, Cultured

1998
Synthesis of 9-O-substituted derivatives of 9-hydroxy-5, 6-dimethyl-6H-pyrido[4,3-b]carbazole-1-carboxylic acid (2-(dimethylamino)ethyl)amide and their 10- and 11-methyl analogues with improved antitumor activity.
    Journal of medicinal chemistry, 1999, Jun-17, Volume: 42, Issue:12

    Topics: Animals; Antineoplastic Agents; Cell Division; Drug Screening Assays, Antitumor; Ellipticines; Inhibitory Concentration 50; Leukemia P388; Melanoma, Experimental; Methylation; Mice; Neoplasm Transplantation; Structure-Activity Relationship; Tumor Cells, Cultured

1999